SELLAS Life Sciences Group, Inc. (SLS)

Healthcare · Biotechnology · NASDAQ

SELLAS Life Sciences Group, Inc. (SLS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.43B and a free-cash-flow yield of -2.2%.

Market cap	$2.43B
Trailing P/E	—
FCF yield	-2.2%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live SLS data on Nama Insights →